Actively Recruiting

Age: 18Years +
All Genders
ID06687590

POst-Market ClINical Follow-up STudy oF the SerranatOR PTA Serration Balloon CathEter

Led by Cagent Vascular LLC · Updated on 2026-05-07

500

Participants Needed

19

Research Sites

8 weeks

Total Duration

On this page

Sponsors

C

Cagent Vascular LLC

Lead Sponsor

Y

Yale Cardiovascular Research Group

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are collecting observational data to evaluate the safety and performance of the Serranator4 balloon catheter in treating peripheral artery disease (PAD) and dysfunctional native or synthetic arteriovenous dialysis fistulae. This registry study observes patients treated under routine medical care to gather real-world evidence for clinical evaluation. Participants will undergo serration balloon angioplasty targeting arteries such as the iliac, femoral, iliofemoral, popliteal, infrapopliteal, and pedal arteries, or dysfunctional dialysis fistulae. The study includes subjects with claudication or ischemic rest pain who have new or recurrent lesions in these areas. During the study, data on peri-procedural performance and safety endpoints will be collected while participants receive standard care. The researchers will monitor outcomes related to the device's use in real-world settings. Participation involves observation and data gathering without altering usual treatment, continuing until the study ends in August 2026.

CONDITIONS

Brief Title

Serranator POINT FORCE Registry

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Intended treatment with Serranator4 for new or recurrent lesions in specific arteries or dysfunctional arteriovenous dialysis fistulae
  • Presence of claudication or critical limb-threatening ischemia classified as Rutherford Clinical Category 3, 4, 5, or 6 in the target limb
  • Age over 18 years
  • Informed consent provided by the subject or legal representative
Not Eligible

You will not qualify if you...

  • Any medical condition making treatment with Serranator4 inappropriate as per instructions or investigator judgment
  • Current enrollment in other investigational studies that could affect the study's endpoints

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Peri-procedural period

Participants undergo serration balloon angioplasty of affected arteries or dysfunctional arteriovenous dialysis fistulae using the Serranator device.

1 procedure visit

Long-term Monitoring

Duration - Up to several months post-procedure

Participants are observed following the angioplasty to assess performance and safety outcomes.

Follow-up visits as per routine clinical care

Trial Site Locations

Total: 19 locations

1

HonorHealth

Scottsdale, Arizona, United States, 85251

Actively Recruiting

2

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048

Actively Recruiting

3

Hartford HealthCare

Hartford, Connecticut, United States, 06102

Actively Recruiting

4

MedStar Washington Hospital / MedStar Montgomery

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

5

Manatee Memorial

Bradenton, Florida, United States, 34208

Actively Recruiting

6

Radiology and Imaging Specialists

Lakeland, Florida, United States, 33801

Actively Recruiting

7

Henry Ford Health

Detroit, Michigan, United States, 48202

Actively Recruiting

8

Barnes Jewish

St Louis, Missouri, United States, 63141

Actively Recruiting

9

Atlantic Medical Imaging

Brick, New Jersey, United States, 08724

Actively Recruiting

10

Virtua Health

Marlton, New Jersey, United States, 08053

Actively Recruiting

11

Northwell

New Hyde Park, New York, United States, 11042

Actively Recruiting

12

Ohio State University Medical Center

Columbus, Ohio, United States, 43210

Actively Recruiting

13

Miami Valley Hospital

Dayton, Ohio, United States, 45409

Actively Recruiting

14

Oregon Health & Sciences University

Portland, Oregon, United States, 97239

Actively Recruiting

15

Penn Presbyterian Medical Center

Philadelphia, Pennsylvania, United States, 19104

Active, Not Recruiting

16

Jefferson Einstein

Philadelphia, Pennsylvania, United States, 19141

Actively Recruiting

17

Brown Health

Providence, Rhode Island, United States, 02912

Actively Recruiting

18

Prisma Health

Greenville, South Carolina, United States, 29615

Actively Recruiting

19

Aurora St. Luke's

Milwaukee, Wisconsin, United States, 53215

Actively Recruiting

Loading map...

Research Team

A

Alexis Shewfelt

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Real-World Clinical Evaluation of the Shockwave Intravascula...

Peripheral Artery Disease (PAD)

Actively Recruiting

1 location

Pulse Arrival Time as an Alternative Biomarker to Detect Low...

Peripheral Artery Disease (PAD)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here